Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique

Bartus, 1998, Sustained delivery of proteins for novel therapeutic products, Science, 281, 1161, 10.1126/science.281.5380.1161 Johnson, 1996, A month-long effect from a single injection of microencapsulated human growth hormone, Nat. Med., 2, 795, 10.1038/nm0796-795 Zhu, 2000, Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide), Nat. Biotechnol., 18, 52, 10.1038/71916 Park, 1995, Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein capsulated poly(d,l-lactic acid-co-glycolic acid) microspheres, J. Controlled Release, 33, 211, 10.1016/0168-3659(94)00084-8 Ogawa, 1988, Controlled release of leuprolide acetate from polylactic acid and copoly(lactic/glycolic)acid microcapsules: influence of molecular weight and copolymer ratio of polymer, Chem. Pharm. Bull., 36, 1502, 10.1248/cpb.36.1502 Okada, 1994, Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers, Pharm. Res., 11, 1143, 10.1023/A:1018936815654 Sah, 1999, Protein behavior at the water/methylene chloride interface, J. Pharm. Sci., 88, 1320, 10.1021/js9900654 Sah, 1999, Stabilization of proteins against methylene chloride/water interface induced denaturation and aggregation, J. Controlled Release, 58, 143, 10.1016/S0168-3659(98)00148-5 van de Weert, 2000, The effect of water/organic solvent interface on the structural stability of lysozyme, J. Controlled Release, 68, 351, 10.1016/S0168-3659(00)00277-7 Putney, 1998, Improving protein therapeutics with sustained-release formulations, Nat. Biotechnol., 16, 153, 10.1038/nbt0298-153 Constantino, 1998, Effects of excipients on the stability and structure of lyophilized recombinant human growth hormone, J. Pharm. Sci., 87, 1412, 10.1021/js980069t Bam, 1998, Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions, J. Pharm. Sci., 87, 1554, 10.1021/js980175v Fu, 1999, FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres, J. Controlled Release, 58, 357, 10.1016/S0168-3659(98)00192-8 Cleland, 1997, Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development, Adv. Drug Deliv. Rev., 28, 71, 10.1016/S0169-409X(97)00051-3 Carrasquillo, 2001, Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation, J. Pharm. Pharmacol., 53, 115, 10.1211/0022357011775091 Castellanos, 2001, Prevention of structural perturbations and aggregation upon microencapsulation of bovine serum albumin into poly(lactide-co-glycolide) microspheres using the solid-in-oil-in-water technique, J. Pharm. Pharmacol., 53, 1099, 10.1211/0022357011776487 Morita, 2000, Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly (ethylene glycol) as a protein micronization adjuvant, J. Controlled Release, 69, 435, 10.1016/S0168-3659(00)00326-6 Morita, 2000, Formation and isolation of spherical fine protein microparticles through lyophilization of protein-poly (ethylene glycol) aqueous mixture, Pharm. Res., 17, 1367, 10.1023/A:1007526301331 Morita, 2001, Applicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoir-type microspheres, Eur. J. Pharm. Biopharm., 51, 45, 10.1016/S0939-6411(00)00138-7 Vance, 1999, Growth hormone therapy in adults and children, N. Engl. J. Med., 341, 1206, 10.1056/NEJM199910143411607 Jorgensen, 1990, Pulsatile vs. continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices, J. Clin. Endocrinol. Metab., 70, 1616, 10.1210/jcem-70-6-1616 Laursen, 1994, Metabolic response to growth hormone (GH) administered in a pulsatile, continuous or combined pattern, Endocrinol. Metab., 1, 33 Laursen, 1995, Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients, J. Clin. Endocrinol. Metab., 80, 2410 Tauber, 1993, Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion vs. daily injection of recombinant human GH in GH-deficient children, J. Clin. Endocrinol. Metab., 76, 1135 Cavallo, 1994, Subcutaneous growth hormone administration in growth-hormone-deficient children, Horm. Res., 42, 86, 10.1159/000184153 Cholewinski, 1996, Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein. Calcitonine and human growth hormone in comparison, Pharm. Acta Helv., 71, 405, 10.1016/S0031-6865(96)00049-0 Maa, 1998, Spray-drying of air–liquid interface sensitive recombinant human growth hormone, J. Pharm. Sci., 87, 152, 10.1021/js970308x Yang, 1999, Use of infrared spectroscopy to assess secondary structure of human growth hormone in biodegradable microspheres, J. Pharm. Sci., 88, 161, 10.1021/js980423n O. Nishimura, M. Suenaga, H. Ohmae, S. Tsuji, M. Fujino, An efficient chemical method for removing extra methionine from recombinant methionylated human growth hormone, Chem. Commun. (1998) 1135–1136. Suenaga, 1999, Further studies on the chemical cleavage of an N-terminal extra methionine from recombinant methionylated proteins, J. Chem. Soc., Perkin Trans., 1, 3727, 10.1039/a907961k S. Takada, T. Kurokawa, M. Misaki, K. Taira, Y. Yamagata, Usefulness of rhGH/PLGA microcapsule formulations with respect to their long-term pharmacological action in a newly developed model, J. Pharm. Pharmacol. (submitted for publication). Johnson, 1997, The stabilization and encapsulation of human growth hormone into biodegradable microspheres, Pharm. Res., 14, 730, 10.1023/A:1012142204132 Herbert, 1998, A large-scale process to produce microencapsulated proteins, Pharm. Res., 15, 357, 10.1023/A:1011951626286 Cunningham, 1991, Dimerization of human growth hormone by zinc, Science, 253, 545, 10.1126/science.1907025 Y. Yamagata, M. Misaki, S. Iwasa, Method of producing a sustained-release preparation, U.S. Patent 6,197,350, March 6, 2001. Yamagata, 2003, Preparation of a copoly (dl-lactic/glycolic acid)–zinc oxide complex and its utilization to microcapsules containing recombinant human growth hormone, Int. J. Pharm., 251, 133, 10.1016/S0378-5173(02)00596-3 Jones, 1996, Technical and regulatory hurdles in delivery aspects of macromolecular drugs, J. Controlled Release, 41, 147, 10.1016/0168-3659(96)01364-8